EMILY MRZLOCK: Open Payments
NPI 1679110266 · DYER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 23 payments from 14 companies in 2025. Trend: 2023 $344 · 2024 $329 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $79 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| PFIZER INC. | 3 | $50 |
| Lilly USA, LLC | 2 | $47 |
| Novo Nordisk Inc | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Organon LLC | 1 | $22 |
| Genentech USA, Inc. | 1 | $19 |
Products named: REXULTI, QULIPTA, MOUNJARO, SHINGRIX, INSPIRE, VRAYLAR, Auvelity, NEXPLANON.
Industry payments across IN — which companies pay providers there.
